Dopamine agonist increases risk taking but blunts reward-related brain activity. - Test2 - elhamkhani - TriplyDB

Dopamine agonist increases risk taking but blunts reward-related brain activity.

Dopamine agonist increases risk taking but blunts reward-related brain activity.

http://www.wikidata.org/entity/Q33346213

about

A combination of dopamine genes predicts success by professional Wall Street traders Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults The risky business of dopamine agonists in Parkinson disease and impulse control disorders.Assessment of reward responsiveness in the response bias probabilistic reward task in rats: implications for cross-species translational research.Reward networks in the brain as captured by connectivity measures Dopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging.Competition between learned reward and error outcome predictions in anterior cingulate cortex The role of dopamine in risk taking: a specific look at Parkinson's disease and gambling The roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humans A new approach to assess gambling-like behavior in laboratory rats: using intracranial self-stimulation as a positive reinforcer.Role of dopamine D2 receptors in human reinforcement learning Deep brain stimulation of nucleus accumbens region in alcoholism affects reward processing DAT1 polymorphism is associated with risk taking in the Balloon Analogue Risk Task (BART).Serotonin and dopamine play complementary roles in gambling to recover losses.Levodopa administration modulates striatal processing of punishment-associated items in healthy participants.Impulsive actions and choices in laboratory animals and humans: effects of high vs. low dopamine states produced by systemic treatments given to neurologically intact subjects Relative gains, losses, and reference points in probabilistic choice in rats.Impulse control disorders in Parkinson's disease: seeking a roadmap toward a better understanding.Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study Effects of acute pramipexole on male rats' preference for gambling-like rewards II.Functional Genetic Variation in Dopamine Signaling Moderates Prefrontal Cortical Activity During Risky Decision Making.The effect of a dopamine antagonist on conditioning of sexual arousal in women Dopamine modulates risk-taking as a function of baseline sensation-seeking trait.Effects of acute pramipexole on preference for gambling-like schedules of reinforcement in rats.Functional connectivity of reward processing in the brain.Impulsivity and apathy in Parkinson's disease.Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers.Dopaminergic influences on emotional decision making in euthymic bipolar patients Impulsivity and risk taking in bipolar disorder and schizophrenia.A novel risk-based decision-making paradigm.Peril and pleasure: an rdoc-inspired examination of threat responses and reward processing in anxiety and depression.DRD4 and striatal modulation of the link between childhood behavioral inhibition and adolescent anxiety.Cocaine addiction is associated with abnormal prefrontal function, increased striatal connectivity and sensitivity to monetary incentives, and decreased connectivity outside the human reward circuit.How attentional boost interacts with reward: the effect of dopaminergic medications in Parkinson's disease.Noradrenergic modulation of risk/reward decision making.The neural basis of impulsive discounting in pathological gamblers.Amplified Striatal Responses to Near-Miss Outcomes in Pathological Gamblers Effects of pramipexole on impulsive choice in male wistar rats Pramipexole-induced increased probabilistic discounting: comparison between a rodent model of Parkinson's disease and controls.The effects of COMT (Val108/158Met) and DRD4 (SNP -521) dopamine genotypes on brain activations related to valence and magnitude of rewards.

P2860

Q21560873-7358F05C-EC49-4987-8CE5-F414CE6899B0 Q27306943-7C790D61-BC5A-4914-910D-1F504FCD8976 Q30425695-B8DE1917-EDBE-4906-894A-0E2766748811 Q30543797-30C62B8E-F1A3-435B-86CB-7982501CFFE1 Q33552301-BFBBF57B-A3ED-4A2F-9310-06D81545A768 Q33593384-961A3516-427D-432E-A838-320EF18261E6 Q33638685-73A50F62-0834-4DA1-9CEB-50649D59536B Q33687660-A6891919-350C-464C-89DE-898B39E1DCD3 Q33706269-45C86463-5FFF-4E7E-B104-50A1551AE10E Q33738220-1A6D06EC-DD41-4E79-BA31-495E9245EE5C Q34068893-E00948D4-DA4D-45A3-8DFF-8037823039BF Q34281618-AA7A4A0B-7669-467C-A4AE-B7A1AE402E86 Q34314211-B3E8F976-2FFC-4636-88CB-1246EB4FB35A Q34661794-677637CC-9731-4241-94BD-67DD497CDC86 Q34694053-BB092E46-B71C-4479-8153-DDC8BDC69644 Q34763315-E5DA2AD6-836A-4F59-8708-0C49DFA72638 Q35057850-C78B064B-C6AF-43DB-8DD4-6BD85282EB31 Q35402798-4C980074-63C8-4E7A-B207-2D75BECEC8E5 Q36341411-0CBF2D08-B4CD-46D3-A5D8-B4902618DD99 Q36350266-182521A8-2D79-4883-885A-113CC368BB34 Q36449651-1B3F752F-CDB8-4C40-A01D-3DDF15B16CC6 Q36712693-BD1B23E2-EDD0-4C01-BCA8-74275732FFC7 Q37076311-1DF4BA2F-352B-4580-99C5-485477FB4CDA Q37106717-4C0CF479-7FA9-40B0-8261-D1B4A1D0EDA8 Q37108506-C50F39FE-8623-493B-82D3-40732676F2A2 Q37331607-91A9FB80-BF47-4648-BE4B-55938E432906 Q37345319-96A00BFE-A805-4BEF-87F2-EF894732B54F Q37409558-B4478C25-3BC5-4A6B-92AF-678A90E2DB05 Q37409611-7AEE2163-EC5D-42F7-8BA5-51F69E960C8B Q37587179-636AAE38-F028-496C-A38D-48B746E03C74 Q37633514-486C3A7C-1025-4BD4-BB03-8755A96C2476 Q37706695-D7D3DDBF-6462-4C9C-9FA4-6B381C57A2F1 Q40087440-2402C5B9-A124-4856-95BC-48D9AF798ABD Q40135602-15A340E6-728E-424E-9541-898B135119D6 Q41243157-3F95C34D-6143-4414-BB72-B474D86AB51D Q41490935-8406A745-8B6B-48FD-9714-B27D96CBEE00 Q41725334-4FCF4C23-B5A8-4578-8592-C3A11044744D Q41786141-651BE925-B2EF-423C-8FAA-E13EB5748447 Q41965607-764F2D65-D16F-484E-ABB7-BDE1F3DD0D00 Q43206196-3B9392A9-1AA4-43D9-BBA3-974D09F5E20C

P2860

Dopamine agonist increases risk taking but blunts reward-related brain activity.

http://www.wikidata.org/entity/Q33346213

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Dopamine agonist increases risk taking but blunts reward-related brain activity.

@ast

Dopamine agonist increases risk taking but blunts reward-related brain activity.

@en

type

label

Dopamine agonist increases risk taking but blunts reward-related brain activity.

@ast

Dopamine agonist increases risk taking but blunts reward-related brain activity.

@en

prefLabel

Dopamine agonist increases risk taking but blunts reward-related brain activity.

@ast

Dopamine agonist increases risk taking but blunts reward-related brain activity.

@en

P1433

Q33346213-E806B2CC-E288-43D2-8D9E-214CF8216B74

P1476

Q33346213-044D12F8-A347-446B-9BB3-B01BD42250FF

P2093

Q33346213-580530A2-D766-490F-882E-F74BE3C60682

Q33346213-800C8068-19AB-4F29-A89B-9FD583619CB7

Q33346213-AA8729CA-74CF-4836-89C4-86856899CD1F

Q33346213-AE3F3578-C0C9-4B77-9C67-3E94DF092188

P2860

Q33346213-265C5370-4082-4600-8DE4-212A8FA650CD

Q33346213-2710ACA0-9A5C-4A87-B3B8-F3649A3E21A6

Q33346213-2E7E935C-F2D5-44E5-8E37-30C376C2CF3B

Q33346213-3C7C9D1D-990D-40B1-8361-97AC7B51D0E6

Q33346213-61EC0BF0-D3F3-4D8C-8D2F-59D0383671B9

Q33346213-6835B72E-22A4-4B10-B414-274DF146ECEF

Q33346213-76054EF6-6ABE-4FA8-A13D-991C04BF2623

Q33346213-8638BCBB-379C-450D-971D-29B4400F324B

Q33346213-872AA09F-177F-4119-A20B-9C9EB5A1ED4F

Q33346213-9CC1D261-C378-48AE-A5FC-C2F85B71B3AE

P304

Q33346213-D4766E63-51F8-4A70-BDB4-0F8798DFAEE7

P31

Q33346213-949EFD53-6525-4DF6-97D4-7501A9B7D6E7

P356

Q33346213-B4EB207B-AF78-4722-8DAE-D238320A46E7

P407

Q33346213-0276A650-1CEC-469B-A964-E1D805A07EAA

P433

Q33346213-CB003AAC-5020-4656-9001-7E266553BF13

P478

Q33346213-31D45679-534B-475F-B37E-3967089F9BF3

P50

Q33346213-328C1941-67BF-4793-91A2-5C8C65777800

P577

Q33346213-74B37AA3-532F-4C39-9A10-64F01BF099D7

P5875

Q33346213-92199985-78E5-4C84-B78C-F6F8AA7CCA4C

P698

Q33346213-81D35FB7-5883-4FDB-8A6F-9812C6FB671E

P921

Q33346213-ea758999-9ae4-4690-a20f-70d726f65b43

P932

Q33346213-6423C462-7211-4522-B482-299A65310F8A

P356

JOURNAL.PONE.0002479

P1433

P1476

Dopamine agonist increases risk taking but blunts reward-related brain activity

@en

P2093

Marcus Heldmann

http://www.w3.org/2001/XMLSchema#string

Sylvia Richter

http://www.w3.org/2001/XMLSchema#string

Thomas F Münte

http://www.w3.org/2001/XMLSchema#string

Ulrike M Krämer

http://www.w3.org/2001/XMLSchema#string

P2860

Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats

Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A

The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats

Linking nucleus accumbens dopamine and blood oxygenation.

Pathological gambling caused by drugs used to treat Parkinson disease.

Association of dopamine agonist use with impulse control disorders in Parkinson disease.

The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders.

Brain reward systems and compulsive drug use.

Reward-related responses in the human striatum.

Dopamine neurons report an error in the temporal prediction of reward during learning.

P304

e2479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0002479

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-06-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5279898

http://www.w3.org/2001/XMLSchema#string

P698

18575579

http://www.w3.org/2001/XMLSchema#string

P921

P932

2423613

http://www.w3.org/2001/XMLSchema#string